Trials / Unknown
UnknownNCT02375152
Safety and Effectiveness of Capsulotomy in Refractory OCD
Safety and Effectiveness of Capsulotomy in Refractory Obsessive-Compulsive Disorder
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Obsessive-compulsive disorder (OCD) is a severely disabling psychiatric disorder with a worldwide lifetime prevalence of 2-3% (Islam et al., 2015).Despite the efficacy of pharmacological and behavioural treatment methods for most OCD patients, roughly one third do not demonstrate significant symptom improvement, even after aggressive treatment (Foa et al, 2007). The effectiveness of neurosurgical treatment methods (including ablative surgery) for those with severely disabling treatment resistant OCD is substantiated by clinical research (Greenberg, Rauch \& Haber, 2010). The brain target of this procedure is usually the area between the anterior and middle third of the anterior limb of the internal capsule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Anterior Capsulotomy |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2015-03-02
- Last updated
- 2015-04-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02375152. Inclusion in this directory is not an endorsement.